COMPARISON OF A NEW FORMULATION OF GOSERELIN (Pepti 3.6 mg) to Zoladex® 3.6 mg
Status:
Completed
Trial end date:
2020-06-07
Target enrollment:
Participant gender:
Summary
The comparator drug (Zoladex 3.6 mg) is approved for use as a thinning agent for the
endometrium prior to endometrial ablation. The dosing recommendation is one or two depots
with each depot given four weeks apart. When two depots are administered, surgery should be
performed within two to four weeks following administration of the second depot.